Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-24-108962

SrVP/CFO/Prin Fin & Acct Ofcr bought 50 shares at $2.46 ($123)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr 2024-10-11 Purchase +50 $2.46 $123 19,368 D
Open-market purchases · 50 sh · avg $2.46 · $123
Loading xslF345X05/tm2426059-2_4seq1.xml…